Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Markus Schwertfeger"'
Publikováno v:
Vascular Health and Risk Management, Vol 2009, Iss default, Pp 991-1000 (2009)
Roland E Schmieder1, Markus Schwertfeger2, Peter Bramlage31Department of Nephrology and Hypertension, University Hospital of Erlangen; Germany; 2Sanofi-Aventis Deutschland GmbH, Berlin, Germany; 3Institute of Cardiovascular Pharmacology and Epidemiol
Externí odkaz:
https://doaj.org/article/6e61d741e71e4593a3a9c1768297e7f7
Autor:
David Pittrow, Gerhart Tepohl, Jens R. Allenberg, Harald Darius, Ina Burghaus, Markus Schwertfeger, Hans J. Trampisch, Roman L. Haberl, Curt Diehm
Publikováno v:
Atherosclerosis. 214:364-372
Objective We aimed to investigate whether the post-exercise ankle brachial index (ABI) performed by primary care physicians offers useful information for the prediction of death or cardiovascular events, beyond the traditional resting ABI. An additio
Publikováno v:
Experimental and Toxicologic Pathology. 54:393-399
Summary The renal handling of porphyrins is reported to be a sensitive marker for chronic renal failure (CRF) for two reasons: heme is synthesised in proximal tubules and porphyrins are reabsorbed in the renal proximal tubule by apical peptide transp
Publikováno v:
Kidney International. 59:S14-S18
Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Background Nitric oxide (NO) synthesis is inhibited by the ADMA that accumulates in the plasma of patients with renal failure; however, the con
Autor:
Christopher F. Bladin, D. Dormont, Masafumi Harada, Astrid M. Vicente, Kenneth Butcher, Delphine Michel-Monigadon, Kristina Szabo, Sofia A. Oliveira, Marta Rubiera, Heinz G. Endres, Jeroen Hendrikse, Sophie Domingues-Montanari, Klaus Berger, S. Crozier, Marc Ribó, Gerhart Tepohl, Natalia Corbeto, Marimar Freijo, Christophe Bonny, Joan Martí-Fàbregas, Christopher R Levi, A. Drier, K.M. Kasius, Jens-Rainer Allenberg, Nikolai Steffenhagen, G.J.E. Rinkel, Jessica Fernández-Morales, Joan Montaner, C. van Heugten, Willem P.Th.M. Mali, Bruce Ovbiagele, Imanuel Dzialowski, Dirk Sander, Naomi Morita, S. Deltour, Ryuuji Kaji, Junichiro Satomi, Maite Mendioroz, Georg Bohner, Joaquín Serena, Angelika Alonso, Lorenz Hirt, M. Coudert, Shelagh B. Coutts, Hiromu Nishitani, C.J.M. Frijns, Stephen M. Davis, Jochen B. Fiebach, José Alvarez-Sabín, P. Renou, D. Galanaud, Kotaro Asanuma, Israel Fernandez-Cadenas, Masaaki Uno, Roman L. Haberl, Geoffrey A. Donnan, A. Algra, Soren Christensen, Stefano Ricci, Markus Schwertfeger, Sarah J. Foster, P. Alan Barber, Curt Diehm, Ina Burghaus, Helena Manso, Saskia H. Meves, Patricia Desmond, David Pittrow, Michael G. Hennerici, José M. Ferro, Y. Samson, T. Tourdias, Andrew M. Demchuk, Meng Lee, Victor Obach, Alberto del Rio-Espinola, Frans L. Moll, Lisa M. Jongen, Christine O'Reilly, Shinji Nagahiro, H. Bart van der Worp, João Sobral, Volker Puetz, M.W.M. Post, Bruce C.V. Campbell, Tiago Krug, M.J.E. van Zandvoort, I. Sibon, Stefan H. Kreisel, C. Rosso, J.M.A. Visser-Meily, Harald Darius, Liliana Gouveia, P.E.C.A. Passier, F. Rouanet, Michael D. Hill, Yuishin Izumi, Mark W Parsons, Hans-Joachim Trampisch
Publikováno v:
Cerebrovascular Diseases. 29:614-616
Autor:
Curt Diehm, Jens-Rainer Allenberg, Markus Schwertfeger, Ina Burghaus, Saskia H. Meves, Hans-Joachim Trampisch, David Pittrow, Gerhart Tepohl, Heinz G. Endres, Klaus Berger, Harald Darius, Roman L. Haberl
Publikováno v:
Cerebrovasc Dis 2010;29:546–554, ISSN: 1015-9770
Background:There is controversial evidence with regard to the significance of peripheral arterial disease (PAD) as an indicator for future stroke risk. We aimed to quantify the risk increase for mortality and morbidity associated with PAD. Methods:In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6a574242316eadcb39d39fd49bf2d47
https://tud.qucosa.de/id/qucosa:26583
https://tud.qucosa.de/id/qucosa:26583
Publikováno v:
Vascular Health and Risk Management
Scopus-Elsevier
Vascular Health and Risk Management, Vol 2009, Iss default, Pp 991-1000 (2009)
Scopus-Elsevier
Vascular Health and Risk Management, Vol 2009, Iss default, Pp 991-1000 (2009)
RolandE Schmieder1, Markus Schwertfeger2, Peter Bramlage31Department of Nephrology and Hypertension, University Hospital of Erlangen; Germany; 2Sanofi-Aventis Deutschland GmbH, Berlin, Germany; 3Institute of Cardiovascular Pharmacology and Epidemiolo
Autor:
Andreas Schirmer, Markus Schwertfeger, Wolfgang Böcking, Heinz G. Endres, Wilhelm Kirch, Curt Diehm, PD Dr. habil David Pittrow
Publikováno v:
Prävention und Versorgungsforschung ISBN: 9783540730415
Zahlreiche epidemiologische Studien konnten den Zusammenhang zwischen einer peripheren arteriellen Verschlusskrankheit (PAVK) und vorzeitigem Tod sowie erhohten koronaren bzw. zerebrovaskularen Ereignisraten belegen. Hieraus lasst sich unmittelbar di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df44a06cf015d76274fbd1249a72c02b
https://doi.org/10.1007/978-3-540-73042-2_40
https://doi.org/10.1007/978-3-540-73042-2_40
Autor:
Joachim Röther, Christiane Binz, Tobias Limbourg, Klaus G. Parhofer, Markus Schwertfeger, David Pittrow, Uwe Zeymer
Publikováno v:
Clinical research in cardiology : official journal of the German Cardiac Society. 98(4)
Peripheral arterial disease (PAD) and coronary artery disease (CAD) are manifestations of the same underlying condition, atherothrombosis. We compared patients with PAD only with those having PAD and concomitant documented CAD in terms of characteris